Share-based Payment Arrangement, Expense of Estrella Immunopharma, Inc. from 31 Dec 2022 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Estrella Immunopharma, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2022 to 30 Sep 2025.
  • Estrella Immunopharma, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $152,421.
  • Estrella Immunopharma, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $1,194,653, a 192% increase from 2023.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Estrella Immunopharma, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $152,421 +$152,421 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $159,098 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $159,095 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q3 2024 $0 -$1,194,653 -100% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2024 2025 Q1
Q3 2023 $1,194,653 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2025 Q1
Q1 2023 $102,399 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q3
Q4 2022 $102,399 01 Oct 2022 31 Dec 2022 10-Q 14 Feb 2024 2023 Q2

Estrella Immunopharma, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $1,194,653 +$785,058 +192% 01 Jul 2023 30 Jun 2024 10-KT 25 Mar 2025 2024 FY
2023 $409,595 01 Jul 2022 30 Jun 2023 10-K 27 Sep 2024 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.